Product Code: GVR-4-68040-453-7
Pharmaceutical Inspection Machines Market Growth & Trends:
The global pharmaceutical inspection machines market is anticipated to reach USD 1.62 billion by 2030, growing at a CAGR of 9.9%, according to a report by Grand View Research, Inc. This growth trajectory is driven by several critical factors, including the increasing prevalence of chronic and complex diseases, stringent regulatory requirements, technological advancements, and expanding pharmaceutical outsourcing. As the industry evolves, stakeholders are increasingly investing in advanced inspection systems to ensure product quality, meet regulatory standards, and address the complexities of modern drug formulations.
The growing prevalence of chronic diseases and complex drug formulations significantly drives the demand for sophisticated inspection technologies. As treatments for conditions such as cancer, diabetes, and cardiovascular diseases evolve, there is a corresponding need for advanced inspection systems capable of handling new drug formulations and biologics. These include large molecules like monoclonal antibodies and gene therapies, which require high-precision inspection to ensure efficacy and safety.
Innovations in artificial intelligence (AI) and machine learning (ML) have transformed inspection systems, enhancing their accuracy and efficiency. AI-powered vision systems can now detect minute defects in real time with high resolution, which is crucial for complex drug formulations and biologics. For instance, integrating AI into inspection machines, such as those by Syntegon Technology, allows for real-time defect detection and higher detection rates, improving overall product quality and compliance.
Pharmaceutical Inspection Machines Market Report Highlights:
- Based on component, the inspection systems segment dominated the market with a substantial share of 76.0% in 2023 and is also expected to grow at the fastest CAGR of 10.2% during the forecast period. This segment's substantial market share and rapid growth can be attributed to the increasing complexity of pharmaceutical products, stringent regulatory requirements, and ongoing technological advancements.
- Based on type, the fully automated segment held the largest revenue share of more than 40.0% in 2023 and is also expected to grow at the fastest CAGR of 10.5% during the forecast period.
- Based on formulation, the oral segment dominated the global market for pharmaceutical inspection machines in 2023, capturing a substantial revenue share and is also expected to growth at the fastest CAGR during the forecast period. This prominence is primarily driven by the high demand for oral medications and stringent regulatory standards.
- Based on end use, the syringes segment dominated the global market in 2023, capturing a substantial revenue share of 35.8%.
- CROs & CDMOs are anticipated to achieve the fastest CAGR of 10.2% during the forecast period.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Component
- 1.2.2. Type
- 1.2.3. Packaging Type
- 1.2.4. Formulation
- 1.2.5. End Use
- 1.2.6. Regional scope
- 1.2.7. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.4.5.1. Data for primary interviews in North America
- 1.4.5.2. Data for primary interviews in Europe
- 1.4.5.3. Data for primary interviews in Asia Pacific
- 1.4.5.4. Data for primary interviews in Latin America
- 1.4.5.5. Data for Primary interviews in MEA
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Component Outlook
- 2.2.2. Type
- 2.2.3. Packaging Type
- 2.2.4. Formulation
- 2.2.5. End Use
- 2.2.6. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Global Pharmaceutical Inspection Machines Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.2. Market restraint analysis
- 3.3. Global Pharmaceutical Inspection Machines Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
Chapter 4. Global Pharmaceutical Inspection Machines Market: Component Estimates & Trend Analysis
- 4.1. Global Pharmaceutical Inspection Machines Market: Component Dashboard
- 4.2. Global Pharmaceutical Inspection Machines Market: Component Movement Analysis
- 4.3. Global Pharmaceutical Inspection Machines Market by Component, Revenue
- 4.4. Inspection System
- 4.4.1. Inspection System market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.1.1. Vision Inspection System
- 4.4.1.1.1. Vision Inspection System market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.1.1.2. Multifunctional
- 4.4.1.1.2.1. Multifunctional market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.1.1.3. Specialized
- 4.4.1.1.4. Specialized market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.1.2. Leak Detection System
- 4.4.1.2.1. Leak Detection System market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.1.3. Metal Detectors
- 4.4.1.3.1. Metal Detectors market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.1.4. X-ray Inspection System
- 4.4.1.4.1. X-ray Inspection System market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.1.5. Checkweighing System
- 4.4.1.5.1. Checkweighing System market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.1.6. Combination System
- 4.4.1.6.1. Combination System market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.1.7. Others
- 4.4.1.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5. Software
- 4.5.1. Software market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Global Pharmaceutical Inspection Machines Market: Type Estimates & Trend Analysis
- 5.1. Global Pharmaceutical Inspection Machines Market: Type Dashboard
- 5.2. Global Pharmaceutical Inspection Machines Market: Type Movement Analysis
- 5.3. Global Pharmaceutical Inspection Machines Market Estimates and Forecasts, By Type, Revenue (USD Million)
- 5.4. Semi-automated
- 5.4.1. Semi-automated market estimates and forecasts 2018 to 2030 (USD Million)
- 5.5. Fully-automated
- 5.5.1. Fully-automated market estimates and forecasts 2018 to 2030 (USD Million)
- 5.6. Manual
- 5.6.1. Manual market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Global Pharmaceutical Inspection Machines Market: Packaging Estimates & Trend Analysis
- 6.1. Global Pharmaceutical Inspection Machines Market: Packaging Dashboard
- 6.2. Global Pharmaceutical Inspection Machines Market: Packaging Movement Analysis
- 6.3. Global Pharmaceutical Inspection Machines Market Estimates and Forecasts, By Packaging Type, Revenue (USD Million)
- 6.4. Syringes
- 6.4.1. Syringes market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5. Bottles
- 6.5.1. Bottles market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6. Blisters
- 6.6.1. Blisters market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7. Ampoules/Vials
- 6.7.1. Ampoules/Vials market estimates and forecasts 2018 to 2030 (USD Million)
- 6.8. Others
- 6.8.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Global Pharmaceutical Inspection Machines Market: Formulation Estimates & Trend Analysis
- 7.1. Global Pharmaceutical Inspection Machines Market: Formulation Dashboard
- 7.2. Global Pharmaceutical Inspection Machines Market: Formulation Movement Analysis
- 7.3. Global Pharmaceutical Inspection Machines Market Estimates and Forecasts, By Formulation, Revenue (USD Million)
- 7.4. Oral
- 7.4.1. Oral market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.1.1. Tablets/Capsules
- 7.4.1.1.1. Tablets/Capsules market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.1.2. Oral Solutions/Syrups
- 7.4.1.2.1. Oral Solutions/Syrups market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.1.3. Others
- 7.4.1.3.1. Other market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5. Parenteral
- 7.5.1. Parenteral market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6. Other
- 7.6.1. Other market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Global Pharmaceutical Inspection Machines Market: End Use Estimates & Trend Analysis
- 8.1. Global Pharmaceutical Inspection Machines Market: End Use Dashboard
- 8.2. Global Pharmaceutical Inspection Machines Market: End Use Movement Analysis
- 8.3. Global Pharmaceutical Inspection Machines Market Estimates and Forecasts, By End Use, Revenue (USD Million)
- 8.4. Pharmaceutical Companies
- 8.4.1. Pharmaceutical Companies market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5. Biotechnology Companies
- 8.5.1. Biotechnology Companies market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6. CROs & CDMOs
- 8.6.1. CROs & CDMOs market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 9. Global Pharmaceutical Inspection Machines Market: Regional Estimates & Trend Analysis by Component, Type, Packaging and Formulation
- 9.1. Regional Dashboard
- 9.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
- 9.3. North America
- 9.3.1. U.S.
- 9.3.1.1. Key country dynamics
- 9.3.1.2. Regulatory framework/ reimbursement structure
- 9.3.1.3. Competitive scenario
- 9.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 9.3.2. Canada
- 9.3.2.1. Key country dynamics
- 9.3.2.2. Regulatory framework/ reimbursement structure
- 9.3.2.3. Competitive scenario
- 9.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 9.3.3. Mexico
- 9.3.3.1. Key country dynamics
- 9.3.3.2. Regulatory framework/ reimbursement structure
- 9.3.3.3. Competitive scenario
- 9.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
- 9.4. Europe
- 9.4.1. UK
- 9.4.1.1. Key country dynamics
- 9.4.1.2. Regulatory framework/ reimbursement structure
- 9.4.1.3. Competitive scenario
- 9.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 9.4.2. Germany
- 9.4.2.1. Key country dynamics
- 9.4.2.2. Regulatory framework/ reimbursement structure
- 9.4.2.3. Competitive scenario
- 9.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 9.4.3. France
- 9.4.3.1. Key country dynamics
- 9.4.3.2. Regulatory framework/ reimbursement structure
- 9.4.3.3. Competitive scenario
- 9.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
- 9.4.4. Italy
- 9.4.4.1. Key country dynamics
- 9.4.4.2. Regulatory framework/ reimbursement structure
- 9.4.4.3. Competitive scenario
- 9.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 9.4.5. Spain
- 9.4.5.1. Key country dynamics
- 9.4.5.2. Regulatory framework/ reimbursement structure
- 9.4.5.3. Competitive scenario
- 9.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 9.4.6. Norway
- 9.4.6.1. Key country dynamics
- 9.4.6.2. Regulatory framework/ reimbursement structure
- 9.4.6.3. Competitive scenario
- 9.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 9.4.7. Sweden
- 9.4.7.1. Key country dynamics
- 9.4.7.2. Regulatory framework/ reimbursement structure
- 9.4.7.3. Competitive scenario
- 9.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 9.4.8. Denmark
- 9.4.8.1. Key country dynamics
- 9.4.8.2. Regulatory framework/ reimbursement structure
- 9.4.8.3. Competitive scenario
- 9.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
- 9.5. Asia Pacific
- 9.5.1. Japan
- 9.5.1.1. Key country dynamics
- 9.5.1.2. Regulatory framework/ reimbursement structure
- 9.5.1.3. Competitive scenario
- 9.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 9.5.2. China
- 9.5.2.1. Key country dynamics
- 9.5.2.2. Regulatory framework/ reimbursement structure
- 9.5.2.3. Competitive scenario
- 9.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
- 9.5.3. India
- 9.5.3.1. Key country dynamics
- 9.5.3.2. Regulatory framework/ reimbursement structure
- 9.5.3.3. Competitive scenario
- 9.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
- 9.5.4. Australia
- 9.5.4.1. Key country dynamics
- 9.5.4.2. Regulatory framework/ reimbursement structure
- 9.5.4.3. Competitive scenario
- 9.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 9.5.5. South Korea
- 9.5.5.1. Key country dynamics
- 9.5.5.2. Regulatory framework/ reimbursement structure
- 9.5.5.3. Competitive scenario
- 9.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 9.5.6. Thailand
- 9.5.6.1. Key country dynamics
- 9.5.6.2. Regulatory framework/ reimbursement structure
- 9.5.6.3. Competitive scenario
- 9.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
- 9.6. Latin America
- 9.6.1. Brazil
- 9.6.1.1. Key country dynamics
- 9.6.1.2. Regulatory framework/ reimbursement structure
- 9.6.1.3. Competitive scenario
- 9.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 9.6.2. Argentina
- 9.6.2.1. Key country dynamics
- 9.6.2.2. Regulatory framework/ reimbursement structure
- 9.6.2.3. Competitive scenario
- 9.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
- 9.7. MEA
- 9.7.1. South Africa
- 9.7.1.1. Key country dynamics
- 9.7.1.2. Regulatory framework/ reimbursement structure
- 9.7.1.3. Competitive scenario
- 9.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 9.7.2. Saudi Arabia
- 9.7.2.1. Key country dynamics
- 9.7.2.2. Regulatory framework/ reimbursement structure
- 9.7.2.3. Competitive scenario
- 9.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 9.7.3. UAE
- 9.7.3.1. Key country dynamics
- 9.7.3.2. Regulatory framework/ reimbursement structure
- 9.7.3.3. Competitive scenario
- 9.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 9.7.4. Kuwait
- 9.7.4.1. Key country dynamics
- 9.7.4.2. Regulatory framework/ reimbursement structure
- 9.7.4.3. Competitive scenario
- 9.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 10. Competitive Landscape
- 10.1. Company/Competition Categorization
- 10.2. Vendor Landscape
- 10.2.1. List of key distributors and channel partners
- 10.2.2. Key company market share analysis, 2023
- 10.2.3. Anritsu Corporation
- 10.2.3.1. Company overview
- 10.2.3.2. Financial performance
- 10.2.3.3. Component benchmarking
- 10.2.3.4. Strategic initiatives
- 10.2.4. ACG Group
- 10.2.4.1. Company overview
- 10.2.4.2. Financial performance
- 10.2.4.3. Component benchmarking
- 10.2.4.4. Strategic initiatives
- 10.2.5. ANTERAS VISION
- 10.2.5.1. Company overview
- 10.2.5.2. Financial performance
- 10.2.5.3. Component benchmarking
- 10.2.5.4. Strategic initiatives
- 10.2.6. Cognex Corporation
- 10.2.6.1. Company overview
- 10.2.6.2. Financial performance
- 10.2.6.3. Component benchmarking
- 10.2.6.4. Strategic initiatives
- 10.2.7. HEUFT Systemtechnik GmbH
- 10.2.7.1. Company overview
- 10.2.7.2. Financial performance
- 10.2.7.3. Component benchmarking
- 10.2.7.4. Strategic initiatives
- 10.2.8. Ishida Co., Ltd.
- 10.2.8.1. Company overview
- 10.2.8.2. Financial performance
- 10.2.8.3. Component benchmarking
- 10.2.8.4. Strategic initiatives
- 10.2.9. Korber AG
- 10.2.9.1. Company overview
- 10.2.9.2. Financial performance
- 10.2.9.3. Component benchmarking
- 10.2.9.4. Strategic initiatives
- 10.2.10. Keyence Corporation
- 10.2.10.1. Company overview
- 10.2.10.2. Financial performance
- 10.2.10.3. Component benchmarking
- 10.2.10.4. Strategic initiatives
- 10.2.11. Mettler-Toledo International Inc.
- 10.2.11.1. Company overview
- 10.2.11.2. Financial performance
- 10.2.11.3. Component benchmarking
- 10.2.11.4. Strategic initiatives
- 10.2.12. Omron Corporation
- 10.2.12.1. Company overview
- 10.2.12.2. Financial performance
- 10.2.12.3. Component benchmarking
- 10.2.12.4. Strategic initiatives
- 10.2.13. Optel Group
- 10.2.13.1. Company overview
- 10.2.13.2. Financial performance
- 10.2.13.3. Component benchmarking
- 10.2.13.4. Strategic initiatives
- 10.2.14. Robert Bosch GmbH
- 10.2.14.1. Company overview
- 10.2.14.2. Financial performance
- 10.2.14.3. Component benchmarking
- 10.2.14.4. Strategic initiatives
- 10.2.15. Sartorius AG
- 10.2.15.1. Company overview
- 10.2.15.2. Financial performance
- 10.2.15.3. Component benchmarking
- 10.2.15.4. Strategic initiatives
- 10.2.16. Teledyne Technologies Incorporated
- 10.2.16.1. Company overview
- 10.2.16.2. Financial performance
- 10.2.16.3. Component benchmarking
- 10.2.16.4. Strategic initiatives
- 10.2.17. Thermo Fisher Scientific Inc.
- 10.2.17.1. Company overview
- 10.2.17.2. Financial performance
- 10.2.17.3. Component benchmarking
- 10.2.17.4. Strategic initiatives